The future cities of biotech. As big biotechs and pharmas continue their attempt to slash costs by outsourcing research and manufacturing operations and forming partnerships, emerging biotech regions could take some of that business and become actual clusters, suggests a report from the real estate firm Jones Lang LaSalle, which highlighted nine emerging biotech cities.
We’d argue that the firm stretched the meaning of “emerging” with its list — as it features both Minneapolis and Raleigh-Durham, plus well-established biotech hub Seattle (all of which were featured on our top medical cities list, too). The other six areas it says are poised for growth in bitoech are Chicago, Denver, Houston, Florida, Atlanta and Indianapolis.
To read the full, original article click on this link: Report: Chicago, Denver, Houston among future biotech clusters (Morning Read)
